Inflamed Skin (IMAGE) Walter and Eliza Hall Institute Caption Existing medicines could offer a new way to treat inflammatory skin conditions, researchers at the Walter and Eliza Hall Institute and the Royal Melbourne Hospital in Melbourne, Australia, have revealed. The research team discovered skin inflammation relies on a protein called RIPK1, and could be prevented by depleting this protein. The finding offers hope that drugs targeting RIPK1, which are currently in clinical trials, could offer relief to people with skin conditions such as psoriasis. In this image, inflamed skin cells (in red) result in thickening of the skin, typical of psoriasis and other inflammatory skin diseases. Credit Holly Anderton/Walter and Eliza Hall Institute Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.